Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market


Ratio Analysis

You can view the Ratio Analysis for the last 5 years.



RATIOS

Accretion Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 233.44 P/BV 4.27 Book Value ( ₹ ) 49.22
52 Week High/Low ( ₹ ) 220/62 FV/ML 10/1200 P/E(X) 24.15
Book Closure EPS ( ₹ ) 8.70 Div Yield (%) 0.00

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)9.038.489.690.270.25
Diluted EPS (Rs.)9.038.489.690.270.25
Cash EPS (Rs.)9.799.2611.812.672.89
Book Value[Excl.RevalReserv]/Share (Rs.)49.2218.7113.3710.0010.00
Book Value[Incl.RevalReserv]/Share (Rs.)49.2218.7113.3710.0010.00
Revenue From Operations / Share (Rs.)80.6370.2384.1676.4772.46
PBDIT / Share (Rs.)13.6414.6619.415.576.28
PBIT / Share (Rs.)12.5513.7117.293.163.64
PBT / Share (Rs.)11.7711.9514.400.360.33
Net Profit / Share (Rs.)8.708.319.690.270.25
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)16.9120.8723.057.278.66
PBIT Margin (%)15.5619.5220.544.135.02
PBT Margin (%)14.5917.0117.110.470.46
Net Profit Margin (%)10.7811.8411.510.350.35
Return on Networth / Equity (%)17.6744.4472.462.702.56
Return on Capital Employeed (%)24.9867.2755.8417.9918.64
Return On Assets (%)12.6017.0314.320.500.44
Long Term Debt / Equity (X)0.010.071.290.740.94
Total Debt / Equity (X)0.220.922.522.202.47
Asset Turnover Ratio (%)1.541.711.411.530.00
      
LIQUIDITY RATIOS     
      
Current Ratio (X)2.901.441.471.051.01
Quick Ratio (X)1.540.550.480.480.42
Inventory Turnover Ratio (X)3.663.273.034.000.00
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)17.438.336.731.991.90
Interest Coverage Ratio (Post Tax) (%)12.115.734.361.101.08
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)78.940.000.000.000.00
EV / Net Operating Revenue (X)0.880.000.000.000.00
EV / EBITDA (X)5.210.000.000.000.00
MarketCap / Net Operating Revenue (X)0.780.000.000.000.00
Price / BV (X)1.290.000.000.000.00
Price / Net Operating Revenue (X)0.780.000.000.000.00
EarningsYield0.130.000.000.000.00